Davis Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2K Buy
47
+4
+9% +$1.48K 0.01% 220
2026
Q1
$12.6K Hold
43
0.01% 208
2025
Q4
$15.1K Hold
43
0.01% 206
2025
Q3
$13.9K Buy
+43
New +$13.4K 0.01% 205
2025
Q1
$17.8K Hold
41
0.01% 196
2024
Q4
$15.1K Hold
41
0.01% 200
2024
Q3
$21.3K Hold
41
0.02% 195
2024
Q2
$21.9K Hold
41
0.02% 185
2024
Q1
$21.2K Hold
41
0.02% 181
2023
Q4
$19.3K Buy
+41
New +$19K 0.02% 183
2020
Q2
$13K Hold
51
0.02% 176
2020
Q1
$12K Buy
+51
New +$13.9K 0.03% 175

Other funds holding ELV

Davis Capital Management's ELV Position: Q2 2026 in Review

Davis Capital Management increased its Elevance Health (ELV) stake by 9.3% in Q2 2026, buying an estimated $1.48K and bringing the position to 47 shares worth $18.2K. The position accounts for 0.01% of the portfolio, ranked #220.

Davis Capital Management first reported a position in ELV in Q1 2020 and has held it in 12 quarters since. The position peaked at $21.9K in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Davis Capital Management held 47 shares of Elevance Health worth $18.2K as of Q2 2026.
  • Davis Capital Management bought 4 Elevance Health shares in Q2 2026, an estimated $1.48K.
  • Elevance Health made up 0.01% of Davis Capital Management's portfolio in Q2 2026, its #220 holding.
  • Davis Capital Management first reported a position in Elevance Health in Q1 2020 and has held it in 12 quarters since.
  • Davis Capital Management's Elevance Health position peaked at $21.9K in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.